Literature DB >> 16154219

Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer.

Mary Feng1, Siavash Jabbari, Alexander Lin, Carol R Bradford, Douglas B Chepeha, Theodoros N Teknos, Francis P Worden, Christina Tsien, Matthew J Schipper, Gregory T Wolf, Laura A Dawson, Avraham Eisbruch.   

Abstract

BACKGROUND AND
PURPOSE: Predictive factors for local-regional (LR) failures after parotid-sparing, Intensity modulated (IMRT) or 3D conformal radiotherapy for head and neck (HN) cancers were assessed. PATIENTS AND METHODS: One hundred and fifty-eight patients with mostly stages III-IV HN squamous cell carcinoma underwent curative bilateral neck irradiation aimed at sparing the parotid glands. Patient, tumor, and treatment factors were analyzed as predictive factors for LR failure.
RESULTS: Twenty-three patients had LR recurrence (19 in-field and four marginal). No differences were found in the doses delivered to the PTVs of patients with or without in-field recurrences. In univariate analysis, tumor site was highly predictive for LR failure in both postoperative and definitive RT patients. In postoperative RT patients, pathologic tumor size, margin status, extracapsular extension (ECE) and number of lymph node metastases, were also significantly predictive. Multivariate analysis showed tumor site (oropharynx vs. other sites) to be a significant predictor in all patients, and involved margins and number of involved lymph nodes in postoperative patients.
CONCLUSIONS: Clinical rather than dosimetric factors predicted for LR failures in this series, and were similar to those reported following standard RT. These factors may aid in the selection of patients for studies of treatment intensification using IMRT.

Entities:  

Mesh:

Year:  2005        PMID: 16154219     DOI: 10.1016/j.radonc.2005.07.008

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Clinical application of intensity-modulated radiotherapy for head and neck cancer.

Authors:  O Ballivy; R Galiana Santamaría; A Lozano Borbalas; F Guedea Edo
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

Review 2.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

3.  Effect of postradiotherapy neck dissection on nonregional disease sites.

Authors:  Mark C Ranck; Rainier Abundo; Gina Jefferson; Antonia Kolokythas; Barry L Wenig; Ralph R Weichselbaum; Michael T Spiotto
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-01       Impact factor: 6.223

4.  Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers.

Authors:  Daniel E Soto; Marc L Kessler; Morand Piert; Avraham Eisbruch
Journal:  Radiother Oncol       Date:  2008-06-12       Impact factor: 6.280

5.  Postoperative IMRT in head and neck cancer.

Authors:  Gabriela Studer; Katrin Furrer; Bernard J Davis; Sandro S Stoeckli; Roger A Zwahlen; Urs M Luetolf; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2006-10-19       Impact factor: 3.481

6.  Improved normal tissue sparing in head and neck radiotherapy using biological cost function based-IMRT.

Authors:  N Anderson; C Lawford; V Khoo; M Rolfo; D L Joon; M Wada
Journal:  Technol Cancer Res Treat       Date:  2011-12

Review 7.  IMRT for head and neck cancer: reducing xerostomia and dysphagia.

Authors:  XiaoShen Wang; Avraham Eisbruch
Journal:  J Radiat Res       Date:  2016-08       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.